Browsing byAuthorKulasinghe, A

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 18 of 18
Issue DateTitleAuthor(s)
2020-01Application of microfluidic technology in cancer research and therapy.Azadi, S; Aboulkheyr Es, H; Kulasinghe, A; Bordhan, P; Ebrahimi Warkiani, M
2020-11-03Circulating tumour cell clusters: Insights into tumour dissemination and metastasis.Herath, S; Razavi Bazaz, S; Monkman, J; Ebrahimi Warkiani, M; Richard, D; O'Byrne, K; Kulasinghe, A
2018-12-01A Collective Route to Head and Neck Cancer MetastasisKulasinghe, A; Schmidt, H; Perry, C; Whitfield, B; Kenny, L; Nelson, C; Warkiani, ME; Punyadeera, C
2021Emerging role of circulating tumor cells in immunotherapy.Rzhevskiy, A; Kapitannikova, A; Malinina, P; Volovetsky, A; Aboulkheyr Es, H; Kulasinghe, A; Thiery, JP; Maslennikova, A; Zvyagin, AV; Ebrahimi Warkiani, M
2020-10-26Emerging Standards and the Hybrid Model for Organizing Scientific Events During and After The COVID-19 Pandemic.Hanaei, S; Takian, A; Majdzadeh, R; Maboloc, CR; Grossmann, I; Gomes, O; Milosevic, M; Gupta, M; Shamshirsaz, AA; Harbi, A; Burhan, AM; Uddin, LQ; Kulasinghe, A; Lam, C-M; Ramakrishna, S; Alavi, A; Nouwen, JL; Dorigo, T; Schreiber, M; Abraham, A; Shelkovaya, N; Krysztofiak, W; Ebrahimi Warkiani, M; Sellke, F; Ogino, S; Barba, FJ; Brand, S; Vasconcelos, C; Salunke, DB; Rezaei, N
2017-02-15Enrichment of circulating head and neck tumour cells using spiral microfluidic technologyKulasinghe, A; Tran, THP; Blick, T; O'Byrne, K; Thompson, EW; Warkiani, ME; Nelson, C; Kenny, L; Punyadeera, C
2020-10Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer.Kapeleris, J; Kulasinghe, A; Warkiani, ME; Oleary, C; Vela, I; Leo, P; Sternes, P; O'Byrne, K; Punyadeera, C
2020-11-27High-Plex and High-Throughput Digital Spatial Profiling of Non-Small-Cell Lung Cancer (NSCLC).Monkman, J; Taheri, T; Ebrahimi Warkiani, M; O'Leary, C; Ladwa, R; Richard, D; O'Byrne, K; Kulasinghe, A
2021-06-03Isolation of Circulating Tumour Cells in Patients With Glioblastoma Using Spiral Microfluidic Technology – A Pilot StudyBark, JM; Kulasinghe, A; Hartel, G; Leo, P; Warkiani, ME; Jeffree, RL; Chua, B; Day, BW; Punyadeera, C
2017-05-16PD-L1 expressing circulating tumour cells in head and neck cancersKulasinghe, A; Perry, C; Kenny, L; Warkiani, ME; Nelson, C; Punyadeera, C
2019-03-18Phenotypic Characterization of Circulating Lung Cancer Cells for Clinically Actionable Targets.Kulasinghe, A; Kapeleris, J; Cooper, C; Warkiani, ME; O'Byrne, K; Punyadeera, C
2018-08-14The prognostic role of circulating tumor cells (CTCs) in lung cancerKapeleris, J; Kulasinghe, A; Warkiani, ME; Vela, I; Kenny, L; O'Byrne, K; Punyadeera, C
2021The Effects of COVID-19 on the Placenta During Pregnancy.Rad, HS; Röhl, J; Stylianou, N; Allenby, MC; Bazaz, SR; Warkiani, ME; Guimaraes, FSF; Clifton, VL; Kulasinghe, A
2020-01The evolving landscape of predictive biomarkers in immuno-oncology with a focus on spatial technologies.Sadeghi Rad, H; Bazaz, SR; Monkman, J; Ebrahimi Warkiani, M; Rezaei, N; O'Byrne, K; Kulasinghe, A
2021-07-19The Pandora’s Box of novel technologies that may revolutionize lung cancerRad, HS; Rad, HS; Shiravand, Y; Radfar, P; Arpon, D; Warkiani, ME; O'Byrne, K; Kulasinghe, A
2020-06-15The Use of Three-Dimensional DNA Fluorescent In Situ Hybridization (3D DNA FISH) for the Detection of Anaplastic Lymphoma Kinase (ALK) in Non-Small Cell Lung Cancer (NSCLC) Circulating Tumor Cells.Kulasinghe, A; Lim, Y; Kapeleris, J; Warkiani, M; O'Byrne, K; Punyadeera, C
2021-01-01Understanding the tumor microenvironment for effective immunotherapy.Sadeghi Rad, H; Monkman, J; Warkiani, ME; Ladwa, R; O'Byrne, K; Rezaei, N; Kulasinghe, A
2018-08-10The use of microfluidic technology for cancer applications and liquid biopsyKulasinghe, A; Wu, H; Punyadeera, C; Warkiani, ME